TrialAntimicrobial agents and chemotherapy2005

Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis.

Robert A Larsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.